Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.680
+0.030 (1.13%)
At close: Jan 9, 2026, 4:00 PM EST
2.730
+0.050 (1.87%)
After-hours: Jan 9, 2026, 7:07 PM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.03 billion as of January 9, 2026. Its market cap has increased by 33.76% in one year.
Market Cap
1.03B
Enterprise Value
253.06M
1-Year Change
33.76%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $1.03B, a decrease of -9.69%. That is a compound annual growth rate of -1.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.03B | 1.91% |
| Dec 31, 2025 | 1.01B | 30.41% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |